Log in to save to my catalogue

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized...

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2084328782

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy

About this item

Full title

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature nanotechnology, 2018-08, Vol.13 (8), p.746-754

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Checkpoint immunotherapy that inhibits tumour immune evasion has demonstrated significant clinical success. However, the therapeutic response is limited to certain patient populations, and immunotoxicity as well as autoimmunity have compromised the therapeutic benefits. Here, we report on an inherently therapeutic fucoidan–dextran-based magnetic na...

Alternative Titles

Full title

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2084328782

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2084328782

Other Identifiers

ISSN

1748-3387

E-ISSN

1748-3395

DOI

10.1038/s41565-018-0146-7

How to access this item